Deniz A. Uçar

1.1k citations

26 papers · 835 indexed · h-index 14

Co-authors: Jan S. Moreb Blanca Ostmark Steven N. Hochwald Lung-Ji Chang Edward W. Scott John K. Amory Alex Goldstein Shuhong Han
Topics: Cancer Cells and Metastasis (7 papers)Cell Adhesion Molecules Research (5 papers)Epigenetics and DNA Methylation (4 papers)
Cited by: Cancer Research Oncology Immunology and Allergy
Journals: PLoS ONE Cancer Research Oncogene
Partner nations: United States Türkiye Italy

In The Last Decade

Deniz A. Uçar

23 papers receiving 815 citations

Peers

Countries citing papers authored by Deniz A. Uçar

Since Specialization

Citations

This map shows the geographic impact of Deniz A. Uçar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deniz A. Uçar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deniz A. Uçar more than expected).

Fields of papers citing papers by Deniz A. Uçar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deniz A. Uçar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deniz A. Uçar. The network helps show where Deniz A. Uçar may publish in the future.

Co-authorship network of co-authors of Deniz A. Uçar

This figure shows the co-authorship network connecting the top 25 collaborators of Deniz A. Uçar. A scholar is included among the top collaborators of Deniz A. Uçar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deniz A. Uçar. Deniz A. Uçar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responses 2022 ·Frontiers in Immunology ·(unknown),Zhi Huang,(unknown),(unknown),(unknown),Ameya S. Champhekar,(unknown),Deniz A. Uçar,Fokhrul Hossain,Salomè V. Ibba,A. Hamid Boulares,(unknown),Keli Xu,Samarpan Majumder,Barbara A. Osborne,(unknown),Lucio Miele	7
2	Diverse and converging roles of ERK1/2 and ERK5 pathways on mesenchymal to epithelial transition in breast cancer 2021 ·Translational Oncology ·(unknown),Thomas D. Wright,(unknown),(unknown),Margarite D. Matossian,(unknown),Deniz A. Uçar,Lucio Miele,Patrick T. Flaherty,Matthew E. Burow,Jane E. Cavanaugh	8
3	Correction: Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor 2021 ·PLoS ONE ·(unknown),Margarite D. Matossian,Steven Elliott,Hope E. Burks,Rachel A. Sabol,Deniz A. Uçar,(unknown),Jovanny Zabaleta,Luis Del Valle,(unknown),Elizabeth C. Martin,Adam I. Riker,Lucio Miele,Bruce A. Bunnell,Matthew E. Burow,Bridgette M. Collins‐Burow	1
4	Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor 2020 ·PLoS ONE ·(unknown),Margarite D. Matossian,Steven Elliott,Hope E. Burks,Rachel A. Sabol,Deniz A. Uçar,(unknown),Jovanny Zabaleta,Luis Del Valle,(unknown),Elizabeth C. Martin,Adam I. Riker,Lucio Miele,Bruce A. Bunnell,Matthew E. Burow,Bridgette M. Collins‐Burow	13
5	Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses 2018 ·Frontiers in Immunology ·Fokhrul Hossain,Samarpan Majumder,Deniz A. Uçar,Paulo C. Rodrı́guez,Todd E. Golde,Lisa M. Minter,Barbara A. Osborne,Lucio Miele	41
6	Notch Signaling Regulates Mitochondrial Metabolism and NF-κB Activity in Triple-Negative Breast Cancer Cells via IKKα-Dependent Non-canonical Pathways 2018 ·Frontiers in Oncology ·Fokhrul Hossain,Claudia Sorrentino,Deniz A. Uçar,Yin Peng,Margarite D. Matossian,Dorota Wyczechowska,Judy S. Crabtree,Jovanny Zabaleta,Silvana Morello,Luis Del Valle,Matthew E. Burow,Bridgette M. Collins‐Burow,Antonio Pannuti,Lisa M. Minter,Todd E. Golde,Barbara A. Osborne,Lucio Miele	76
7	Treatment of hypertriglyceridemia-induced acute pancreatitis with insulin 2015 ·Gastroenterology Review ·Ali Coşkun,Nazif Erkan,Savaş Yakan,Mehmet Yıldırım,(unknown),Deniz A. Uçar,(unknown)	51
8	A FAK scaffold inhibitor disrupts FAK and VEGFR-3 signaling and blocks melanoma growth by targeting both tumor and endothelial cells 2014 ·Cell Cycle ·Elena Kurenova,Deniz A. Uçar,Jianqun Liao,(unknown),(unknown),Wiam Bshara,Ulaş Sunar,Mukund Seshadri,Steven N. Hochwald,William G. Cance	13
9	Inhibiting the Interaction of cMET and IGF-1R with FAK Effectively Reduces Growth of Pancreatic Cancer Cells in vitro and in vivo 2013 ·Anti-Cancer Agents in Medicinal Chemistry ·Deniz A. Uçar,Andrew T. Magis,(unknown),Nicholas J. Lawrence,Saı̈d M. Sebti,Elena Kurenova,Maria Zajac‐Kaye,Jianliang Zhang,Steven N. Hochwald	25
10	Disruption of the protein interaction between FAK and IGF-1R inhibits melanoma tumor growth 2012 ·Cell Cycle ·Deniz A. Uçar,Elena Kurenova,Timothy J. Garrett,William G. Cance,Carl Nyberg,Audrey Cox,Nicole Massoll,David A. Ostrov,Nicholas J. Lawrence,Saı̈d M. Sebti,Maria Zajac‐Kaye,Steven N. Hochwald	39
11	Elevated expression of IRS2 in the progression from neurofibroma to malignant peripheral nerve sheath tumor. 2012 ·PubMed ·Shawna C. Willey,Stephen R. Grobmyer,Deniz A. Uçar,William G. Cance,John D. Reith,Steven N. Hochwald	5
12	Altered LKB1/CREB-regulated transcription co-activator (CRTC) signaling axis promotes esophageal cancer cell migration and invasion 2011 ·Oncogene ·Yumei Gu,Sen Lin,Jian‐Liang Li,Hiroshi Nakagawa,(unknown),Bilian Jin,(unknown),Deniz A. Uçar,Huangxuan Shen,Jianrong Lu,Steven N. Hochwald,Frederic J. Kaye,Lizi Wu	69
13	The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance 2011 ·Chemico-Biological Interactions ·Jan S. Moreb,Deniz A. Uçar,Shuhong Han,John K. Amory,Alex Goldstein,Blanca Ostmark,Lung-Ji Chang	159
14	A Novel Small Molecule Inhibitor of FAK and IGF-1R Protein Interactions Decreases Growth of Human Esophageal Carcinoma 2011 ·Anti-Cancer Agents in Medicinal Chemistry ·Deniz A. Uçar,Audrey Cox,(unknown),David A. Ostrov,Elena Kurenova,Steven N. Hochwald	9
15	Abstract 3582: Targeting the FAK amino terminus F2 subdomain to disrupt growth factor receptor protein interactions, signaling and function 2011 ·Cancer Research ·Deniz A. Uçar,Andrew T. Magis,(unknown),David A. Ostrov,Steven N. Hochwald	1
16	FAK and Interacting Proteins as Therapeutic Targets in Pancreatic Cancer 2010 ·Anti-Cancer Agents in Medicinal Chemistry ·Deniz A. Uçar,Steven N. Hochwald	14
17	Targeting of the protein interaction site between FAK and IGF-1R 2009 ·Biochemical and Biophysical Research Communications ·Donghang Zheng,Elena Kurenova,Deniz A. Uçar,Vita Golubovskaya,Andrew T. Magis,David A. Ostrov,William G. Cance,Steven N. Hochwald	22
18	Aldehyde dehydrogenase activity as a functional marker for lung cancer 2008 ·Chemico-Biological Interactions ·Deniz A. Uçar,Christopher R. Cogle,James R. Zucali,Blanca Ostmark,Edward W. Scott,Robert Zori,Brian A. Gray,Jan S. Moreb	138
19	Epilepsy in Phenylketonuria: A Complex Dependence on Serum Phenylalanine Levels 2007 ·Epilepsia ·Anatoly E. Martynyuk,Deniz A. Uçar,Dawn Yang,Wendy M. Norman,Paul R. Carney,Donn M. Dennis,Philip J. Laipis	23
20	Circadian Variation in Circulating Pyrogen: Possible Role in Resistance to Infection 1983 ·Experimental Biology and Medicine ·Deniz A. Uçar,(unknown),Matthew J. Kluger	20

About Deniz A. Uçar

Deniz A. Uçar is a scholar working on Immunology and Allergy, Oncology and Cancer Research, having authored 26 papers that have together received 835 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (7 papers), Cell Adhesion Molecules Research (5 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Cancer Research (234 citations), Oncology (382 citations) and Immunology and Allergy (61 citations). Deniz A. Uçar has collaborated with scholars based in United States, Türkiye and Italy. Frequent co-authors include Jan S. Moreb, Blanca Ostmark, Steven N. Hochwald, Lung-Ji Chang, Edward W. Scott, John K. Amory, Alex Goldstein, Shuhong Han, Christopher R. Cogle and Brian A. Gray. Their work appears in journals such as PLoS ONE, Cancer Research and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact